Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas
Robert Roskoski
Pharmacological Research (2017) Vol. 120, pp. 116-132
Closed Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Properties of FDA-approved small molecule protein kinase inhibitors
Robert Roskoski
Pharmacological Research (2019) Vol. 144, pp. 19-50
Closed Access | Times Cited: 488
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Robert Roskoski
Pharmacological Research (2019) Vol. 152, pp. 104609-104609
Closed Access | Times Cited: 476
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
Robert Roskoski
Pharmacological Research (2018) Vol. 139, pp. 395-411
Closed Access | Times Cited: 396
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
Pharmacological Research (2018) Vol. 139, pp. 471-488
Closed Access | Times Cited: 327
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Robert Roskoski
Pharmacological Research (2021) Vol. 165, pp. 105463-105463
Closed Access | Times Cited: 305
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
Robert Roskoski
Pharmacological Research (2019) Vol. 142, pp. 151-168
Closed Access | Times Cited: 241
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
Robert Roskoski
Pharmacological Research (2022) Vol. 187, pp. 106552-106552
Open Access | Times Cited: 241
Drug resistance in cancer: mechanisms and tackling strategies
Tanweer Haider, Vikas Pandey, Nagma Banjare, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1125-1151
Closed Access | Times Cited: 216
Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera, Teresa Valero, Álvaro Lorente‐Macías, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1047-1131
Open Access | Times Cited: 192
Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update
Robert Roskoski
Pharmacological Research (2021) Vol. 175, pp. 106037-106037
Closed Access | Times Cited: 189
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
Robert Roskoski
Pharmacological Research (2018) Vol. 135, pp. 239-258
Closed Access | Times Cited: 174
Markers and Biomarkers of Endothelium: When Something Is Rotten in the State
Н. В. Гончаров, А. Д. Надеев, Richard O. Jenkins, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 172
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Robert Roskoski
Pharmacological Research (2024) Vol. 200, pp. 107059-107059
Open Access | Times Cited: 167
Recent progresses in DNA nanostructure-based biosensors for detection of tumor markers
Rongrong Huang, Nongyue He, Zhiyang Li
Biosensors and Bioelectronics (2018) Vol. 109, pp. 27-34
Closed Access | Times Cited: 165
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
Yun Liu, Yang Li, Yuxi Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 104
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis
Robert Roskoski
Pharmacological Research (2023) Vol. 189, pp. 106642-106642
Open Access | Times Cited: 48
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Pedro Miguel Lacal, Grazia Graziani
Pharmacological Research (2018) Vol. 136, pp. 97-107
Closed Access | Times Cited: 149
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Robert Roskoski
Pharmacological Research (2018) Vol. 129, pp. 65-83
Closed Access | Times Cited: 144
The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder
Robert Roskoski
Pharmacological Research (2019) Vol. 151, pp. 104567-104567
Closed Access | Times Cited: 116
ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers
Robert Roskoski
Pharmacological Research (2017) Vol. 121, pp. 202-212
Closed Access | Times Cited: 112
Radiation-induced skin injury: pathogenesis, treatment, and management
Xiaojing Yang, Hanru Ren, Xiaomao Guo, et al.
Aging (2020)
Open Access | Times Cited: 109
Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers
Robert Roskoski, Abdollah Sadeghi‐Nejad
Pharmacological Research (2017) Vol. 128, pp. 1-17
Closed Access | Times Cited: 98
Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy
Wei Zheng, Pingping Liang, Junqi Xie, et al.
Chemical Science (2019) Vol. 10, Iss. 9, pp. 2778-2784
Open Access | Times Cited: 96
Hypoxia Mediates Tumor Malignancy and Therapy Resistance
Weibo Luo, Yingfei Wang
Advances in experimental medicine and biology (2019), pp. 1-18
Closed Access | Times Cited: 79
Page 1 - Next Page

Scroll to top